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doi:10.1016/j.asjsur.2012.04.005Summary Background: Application of minimally invasive techniques in the surgical manage-
ment of distal pancreatic lesions is increasing. Despite this, numbers of laparoscopic distal
pancreatectomy remain low and limited to treatment of benign and premalignant lesions.
Methods: Retrospective analysis of 31 patients who underwent distal pancreatectomy from
2005 to 2010. Patients were grouped according to mode of surgical access: open (ODP) or lapa-
roscopic (LDP). Perioperative parameters were compared.
Results: Twenty-one (67.7%) patients underwent ODP and 10 (32.3%) LDP (median age 61;
80.0% females in LDP group, p Z 0.030). Postoperative morbidity rate were comparable
between the two groups. In the LDP group, there were significantly lower estimated blood loss
(p < 0.001) and amount of blood transfusion (p Z 0.001), smaller tumor size (p Z 0.010) and
fewer lymph nodes harvested (p Z 0.020), shorter postoperative length of stay (p Z 0.020),
and shorter length of stay in surgical high dependency (p Z 0.001).
Conclusion: LDP is a safe, efficient technique for resection of benign and premalignant pancre-
atic lesions. Indices reflecting perioperative outcomes in this study are highly competitive with
those in other major centers.
Copyright ª 2012, Asian Surgical Association. Published by Elsevier Taiwan LLC. All rights
reserved.epatobiliary and Pancreatic Surgery, Digestive Disease Center, Department of Surgery, Tan Tock Seng
il.com (C.K. Ho).
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Over the course of the past quarter century, the progressive
advancement of surgical technologies has been accompa-
nied by a rise in the use of minimally invasive techniques
for the surgical management of several gastrointestinal
conditions. With the development of advanced bioimaging
techniques and their increasing popularity as diagnostic
tools in the clinical approach to abdominal symptoms, more
pancreatic lesions have been detected,1 especially among
young women.2
The safety and feasibility of laparoscopic distal
pancreatectomy (LDP) was first documented in a porcine
model by Soper et al.3 This was then followed by the
earliest reports on LDP carried out in humans by Cuschieri
et al.4 Since then, this procedure has been further exam-
ined in a number of case series and multi-institutional
studies with emphasis on its safety and efficacy.5e7 In
general, it has been found to have comparable post-
operative morbidity rates and shorter lengths of stays in
hospitals when measured up against open distal pancrea-
tectomy (ODP). Despite substantial support for LDP based
on the available literature, to date there are no clear
international guidelines detailing best surgical practices
with regard to the various types of distal pancreatic lesions.
Although there has been a growing interest in the ability
to perform LDP, the number of LDP performed by many
centers remains low.8 A recent review of 72 studies
revealed that centers with higher case volumes have
better clinical outcomes.9 This trend has also been found to
exist with regards to various gastrointestinal operations
such as esophagectomies, gastrectomies and colectomies.
However, it is especially true for pancreatic resections.10
This report presents the results of a retrospective review
in our institution designed to compare perioperative
parameters in the group of patients who underwent LDP to
the group who underwent ODP. Differences in post-
operative outcomes between the 2 treatment groups were
identified and analysed critically.
2. Patients and methods
We performed a retrospective analysis of a prospectively
maintained database of 31 patients who underwent distal
pancreatectomy (DP) for both benign and malignant
conditions in our institution from 2005 to 2010. The patient
cohort was divided into two groups according to the mode
of surgical access: laparoscopic (LDP) or open (ODP) distal
pancreatic resection. The perioperative parameters were
compared between the two groups.
Demographic information and blood parameters were
compared between the two groups, as were the operative
information and histopathology. Postoperative outcome was
examined especially looking at the morbidity and mortality
rates and the length-of-stay (LOS). The definitions of the
common morbidity following pancreatectomy as recom-
mended by the International Study Group for Pancreatic
Surgery (ISGPS) were adopted in this study. They included
postoperative pancreatic fistula (POPF), delayed gastric
emptying and postpancreatectomy hemorrhage.11e13 All
complications were graded according to the classificationproposed by Clavien et al.14e17 Operative mortality was
defined as the rate of death before hospital discharge or
within 30 days after the main surgical procedure.10
All patients with significant cardiac and respiratory
conditions were assessed by cardiologists and respiratory
physicians. Mandatory preoperative cardiac assessments
were conducted on patients older than 65 years; younger
patients were selected on a case-specific basis. All patients
underwent preoperative chest physiotherapy and incentive
spirometry, and smokers were advised to cease smoking for
at least two weeks prior to the operation, to minimize
postoperative respiratory morbidity.18
All 31 distal pancreatic resections were performed by
either open or laparoscopic access. Types of resection
included subtotal pancreatectomy, distal pancreato-
splenectomy, spleen preserving distal pancreatectomy
and radical antegrade modular pancreato-splenectomy
(RAMP). Prior to proceeding with ODP, a thorough diag-
nostic laparoscopy was routinely performed to rule out
obvious peritoneal and liver metastasis.19 In the absence
of distant metastasis, either an upper midline or L-incision
(upper midline with left subcostal extension) was created.
The peritoneal cavity was then examined careful for
metastasis. The lesser sac was entered through gastrocolic
ligament and the pancreatic neck was dissected by
creating a tunnel along superior mesenteric vein/portal
vein axis. The pancreas was transected either with
a surgical stapler with or without buttressing material such
as Seamguard Bioabsorbable Staple Line Reinforcement
(Gore Flagstaff, AZ, USA). Further reinforcement with
non-absorbable continuous sutures such as polypropylene
(Prolene Ethicon, Inc, Johnson & Johnson, Somerville, NJ,
USA) along the transected pancreatic surface was some-
times performed. Next, the splenic artery and vein were
dissected separately. The splenic artery was isolated,
divided, and suture ligated, followed by ligation of splenic
vein. Lymphadenectomy was performed in the medial-to-
lateral direction as far as the splenic hilum. If concur-
rent splenectomy was required, the spleen was mobilized
by dividing the lienorenal, lienocolic, lienoogastric, and
lienophrenic ligaments. In bulky tumors, en bloc resection
of surrounding organs such as stomach, colon, small
bowel, and even a cuff of diaphragm was sometimes
required. In RAMPs, the initial steps of mobilization
involved complete Kocher’s maneuver as far as the left
renal vein crossing the aorta, and this would mark the
posterior extent of peripancreatic tissues to be removed
as part of the lymphovascular clearance in this operation.
The subsequent steps of dissection were largely similar to
those described above. The technique of LDP was previ-
ously described in our publication on laparoscopic spleen-
preserving distal pancreatectomy.20 All patients had one
or two closed drains placed in the peritoneal cavity close
to the transected end of the pancreas.
A standard pancreatic surgery care pathway is used for
postoperative management in the wards. Patients are
kept nil-by-mouth with a Ryle’s tube for passive drainage
and aspiration at 4-hourly intervals. A single dose of
200 mg of subcutaneous sandostatin is administered during
pancreatic transection and this is continued until the
patient resumes a solid diet postoperatively. The post-
operative dose is dependant on the consistency of the
Laparoscopic and open distal pancreatectomy 31pancreatic tissue assessed during operation. If the
pancreas is soft or pancreatic duct is <3 mm, 200 mg at 8-
hourly dosing interval is administered, otherwise 100 mg 8
hourly is given. Patients are allowed nonmilk feeds if
nasogastric output is <100 ml on the first postoperative
day (POD) and the Ryle’s tube is removed on the second
POD if the output remains <100 ml. Feeding is graduated
as tolerated. In general, patients will be taking full diet by
the third POD.21 Drain fluid and serum amylase are per-
formed on the first, third and fifth PODs. The definitions of
pancreatic leak and other complications were according
to ISGPS recommendations as mentioned above.
The data were analyzed using statistical software
(SPSS Statistics 18.0, SPSS Inc, Chicago, IL, USA). Cate-
gorical variables were analyzed using the Chi-square test
while continuous variables were compared using the
Student t test (parametric distribution) or Mann-Whitney
test (nonparametric distribution). All tests were two-
sided and p < 0.050 was considered to be statistically
significant.
3. Results
3.1. Demographics
Ten patients (32.3%) underwent LDP while 21 (67.7%)
underwent ODP. Median age of the cohort was 61 (37e79)
years and the majority were ethnic Chinese (93.5%). The
proportion of female patients in LDP was more than twiceTable 1 Demographic features for the entire cohort.
Demographics All (n Z 31)
Median Range Med
Age 61 37e79 62
n % n
Number of patients 31 100 21
Gender
Male 15 48.4 13
Female 16 51.6 8
Race
Chinese 29 93.5 19
Malay 2 6.5 2
Comorbidities present 25 80.6 17
Hypertension 16 51.6 12
Diabetes mellitus 13 41.9 8
Hyperlipidemia 10 32.3 5
Ischemic heart disease 3 9.7 1
COLD 1 3.2 1
ASA Score
1 1 3.2 0
2 20 64.5 15
3 10 32.3 6
4 0 0 0
^ p values for ODP vs LDP; * Statistically significant.
COLD Z chronic obstructive lung disease.that in ODP (80.0% vs 38.1%, p Z 0.030). However, there
was no difference between the two groups in terms of age
(p Z 0.470), racial distribution (p Z 0.310) and ASA clas-
sification (Table 1).3.2. Preoperative clinical information
Indices of preoperative clinical information are summarized
in Tables 2 and 3. More than 80% of patients had at least one
comorbid condition. The most common comorbidity in both
groups was hypertension (57.1% in ODP vs. 40.0% in LDP,
p Z 0.370). Abdominal pain was the most common
presentation in both groups. No statistically significant
difference was found with regards to other preoperative
clinical information between the two groups of patients.3.3. Intraoperative outcomes
Duration of operation. The overall median length of
operation was 353 (115e660) min. The median duration of
operation in ODP was 330 (115e660) min and the median
duration of operation in LDP was 383 (240e490) min
(p Z 0.500; Table 4).
Lymph node resection. The overall median number of
lymph nodes harvested was 4 (0e29). The median number
of lymph nodes harvested in LDP was 2 (0e11), half that of
the median number of lymph node harvested in ODP 4
(0e29; p Z 0.020; Table 4).ODP (n Z 21) LDP (n Z 10) p ^
ian Range Median Range
37e77 58 42e79 0.472
% n %
67.7 10 32.3 d
0.029*
61.9 2 20.0 d
38.1 8 80.0 d
0.313
90.5 10 100.0 d
9.5 0 0 d
81.0 8 80.0 0.950
57.1 4 40.0 0.372
38.1 5 50.0 0.530
23.8 5 50.0 0.145
4.8 2 20.0 0.180
4.8 0 0 0.483
0.240
0 1 10.0 d
71.0 5 50.0 d
28.0 4 40.0 d
0 0 0 d
Table 2 Comparison of preoperative clinical information.
All (n Z 31) ODP (n Z 21) LDP (n Z 10) p ^
BMI, median (range) 21.8 (18.7e32.5) 21.0 (18.7e28.7) 25.0 (21.8e32.5) 0.112
Clinical presentation, n (%)
Abdominal pain 11 (35.5) 9 (42.9) 2 (20.0) d
Other presentations# 9 (29.0) 6 (28.6) 3 (30.0) d
Weight loss 6 (19.4) 6 (28.6) 0 d
Loss of appetite 3 (9.7) 3 (14.3) 0 d
Abdominal mass 3 (9.7) 3 (14.3) 0 d
Back pain 2 (6.5) 2 (9.5) 0 d
Diarrhea 2 (6.5) 1 (4.8) 1 (10.0) d
Melena 1 (3.2) 1 (4.8) 0 d
Vomiting 1 (3.2) 1 (4.8) 0 d
Acute pancreatitis 0 0 0 d
New onset DM 0 0 0 d
Steatorrhea 0 0 0 d
^ p values for ODP vs LDP; # Abdominal bloatedness/distention, constipation, epigastric discomfort, dizziness, hematemesis,
hypoglycemia.
BMI Z body mass index; DM Z diabetes mellitus.
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median overall EBL was 300 (200e1500) ml. The median
EBL for LDP was 275 (200e300) ml, which was about one-
third of that in ODP (median 600, 200e1500 ml;
p < 0.001). Concomitantly, the median amount of blood
transfusion in ODP was 4 (0e29) units compared to the
median of 2 (0e11) units in the LDP group (p Z 0.001;
Table 4).
Tumor size. The median overall tumor size was 45
(2e170) mm. In the ODP group, the median size of tumors
removed was 50 (14e170) mm, which was significantly
larger than those removed in LDP (median 25, 2e67) mm
(p Z 0.009; Table 5).
Tumor pathology. The most common site of pathology in
this cohort was the pancreatic tail (nZ 19, 61.3%). Similar
distribution of site of pathology was observed in the LDP
and ODP groups (p Z 0.919; Table 5). There was signifi-
cantly higher proportion of malignancy in the ODP group
(n Z 14, 66.7%) as compared to LDP group (n Z 1, 10.0%;
pZ 0.004). Majority of the tumors in LDP was premalignant
(n Z 8, 80.0%). The detailed histopathology information is
listed in Table 5.Table 3 Preoperative blood investigations.
All (n Z 31)
Preoperative hematology, median (range)
Hemoglobin concentration (g/dL) 13.1 (6.8e15.4)
PT (s) 13.1 (11.6e17.0)
PTT (s) 30.5 (24.4e37.2)
Preoperative biochemistry, median (range)
Albumin (g/L) 37.0 (19.0e44.0)
CA 19-9 (U/ml) 18.0 (0.5e4702.0)
^ p values for ODP vs. LDP.
CA Z carbohydrate antigen; PT Z prothrombin time; PTT Z partial3.4. Postoperative outcomes
Morbidity rate. The overall postoperative morbidity rate
was 61.3% in this cohort. The rate of postoperative
morbidity in the LDP group (70.0%) was comparable to that
in the ODP group (57.1%; p Z 0.490). The rate of POPF in
the LDP group was 70.0% (n Z 7) as compared to 42.9%
(n Z 9) in ODP (p Z 0.160; Table 6). However, the vast
majority of them were Grade A POPF, which does not
contribute to significant poor clinical outcome
(ODPZ 77.8%, nZ 7 vs. LDPZ 57.1%, nZ 4; Fig. 1). This
was translated into an overestimation of postoperative
morbidity by approximately 30% in both the ODP and LDP
groups (28.4% and 30.0%, respectively; Fig. 1). There was no
Grade C POPF in either study group. There was no statis-
tical difference between the two groups in terms of the
incidence of delayed gastric emptying and post-
pancreatectomy hemorrhage (Table 6). The rate of wound
infection was also comparable between the two groups
(ODPZ 14.3% vs. LDPZ 10.0%, p Z 0.740).
Postoperative LOS. The median postoperative LOS in
LDP group was 5 (3e8) days, while that in the ODP groupODP (n Z 21) LDP (n Z 10) p ^
13.2 (6.8e15.4) 13.0 (10.2e15.2) 0.667
13.2 (11.6e17.0) 12.8 (12.1e16.4) 0.846
29.8 (24.4e37.2) 30.2 (27.5e34.3) 0.543
36.0 (19.0e44.0) 37.5 (31.0e43.0) 0.831
15.5 (0.5e4702.0) 21.0 (0.5e1619.0) 0.846
thromboplastin time.
Table 4 Intraoperative outcomes.
All (n Z 31) ODP (n Z 21) LDP (n Z 10) p ^
Median operative time: min (range) 353 (115e660) 330 (115e660) 383 (240e490) 0.495
Median estimated blood loss: ml (range) 300 (200e1500) 600 (200e1500) 275 (200e300) <0.001*
Median blood transfusion: units (range) 4 (0e29) 4 (0e29) 2 (0e11) 0.001*
Median lymph nodes harvested (range) 4 (0e29) 4 (0e29) 2 (0e11) 0.020*
^ p values for ODP vs LDP; * Statistically significant.
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longer LOS in the surgical high dependency unit for patients
in the ODP group (median 2, 0e5 days) compared to the LDP
group (median 0, 0e1 days; p Z 0.001; Table 7).
Operative mortality. There was no postoperative or
in-hospital 30-day mortality in this cohort of patients
(Table 7).4. Discussion
Approaches to pancreatic surgery are fast evolving and
expanding continuously. Minimally invasive techniques have
now been developed to the extent that they allow for
surgical resection of pancreatic lesions, debridement, and
drainage of tumors.22e24 Considering the retroperitoneal
location of the pancreas, a laparoscopic approach presents
itself as a procedure with: 1) minimal incisions for entry25;
2) good accessibility to the pancreatic lesion; and 3) closer
and more definitive views.2,26 At the same time, laparo-
scopic approaches have been shown in studies to produce
shorter/similar operation times and LOS in hospital, less
blood loss, and fewer complications when compared to
open access methods, without any compromise on safety of
the procedure.20,27 As such, the trend of using laparoscopicTable 5 Distal pancreatectomies: pathological information of t
All (n Z 31)
Tumor size, median (range), mm 45 (2e170)
Nature of tumor, n (%)
Benign 4 (12.9)
Premalignant 12 (38.7)
Malignant 15 (48.4)
Histopathology, n (%)
Ductal adenocarcinoma 9 (29.0)
MCN (benign) 5 (16.1)
Serous cystadenoma 3 (9.7)
Neuroendocrine tumor (benign) 3 (9.7)
Neuroendocrine tumor (malignant) 2 (6.5)
MCN (malignant) 1 (3.2)
IPMT (benign) 1 (3.2)
IPMT (malignant) 1 (3.2)
Others 6 (19.4)
Location of tumor, n (%)
Pancreatic body 12 (38.7)
Pancreatic tail 19 (61.3)
MCN Z mucinous cystic neoplasm; IPMT Z intraductal papillary muc
^ p values for ODP vs LDP; * Statistically significant.distal pancreatectomy to treat premalignant and benign
pancreatic body and tail lesions has gained increasing
popularity over the years as they are less technically
challenging compared to laparoscopic pan-
creaticoduodenectomy.28,29 Many of the studies comparing
clinical outcomes between LDP and ODP originated from
Europe and the USA.5,6,8 Only in recent years have we
started reading more reports coming from Asian cen-
ters.2,7,30e32 Nonetheless, such data remain limited from
our part of the world. To our knowledge, this series is the
only single-institutional study in our nation comparing
clinical outcomes between LDP and ODP.
Our study yielded several important findings. Firstly, the
preoperative variables such as demographics, comorbid
conditions and blood investigations were comparable
between the two groups, signifying that patients were
relatively alike in terms of their preoperative status and
subsequent comparisons are more meaningful.
Secondly, although some studies showed that LDP had
shorter duration of operation, we found no significant
difference between the two groups in terms of operative
time. We can rationalize this difference as follows: LDP was
technically more challenging compared to ODP, especially
when laparoscopic spleen preservation was required.33e35
However, as the tumor size in the ODP was much largerhe tumor.
ODP (n Z 21) LDP (n Z 10) p ^
50 (14e170) 24.5 (2e67) 0.009*
0.004*
3 (14.3) 1 (10.0) d
4 (19.0) 8 (80.0) d
14 (66.7) 1 (10.0) d
0.068
8 (38.1) 1 (10.0) d
2 (9.5) 3 (30.0) d
2 (9.5) 1 (10.0) d
0 3 (30.0) d
2 (9.5) 0 d
1 (4.8) 0 d
0 1 (10.0) d
1 (4.8) 0 d
5 (23.8) 1 (10.0) d
0.919
8 (38.1) 4 (40.0) d
13 (61.9) 6 (60.0) d
inous tumor.
Table 6 Perioperative morbidity and mortality.
Post-Operative Morbidity All (n Z 31) ODP (n Z 21) LDP (n Z 10) p ^
n % n % n %
Morbidity 19 61.3 12 57.1 7 70.0 0.492
Morbidity without POPF-A 10 32.3 6 28.6 4 40.0 0.525
Mortality 0 0 0 0 0 0 d
General complications
Wound infection 4 12.9 3 14.3 1 10.0 0.739
Specific complications
POPF 16 51.6 9 42.9 7 70.0 0.157
Intra abdominal abscess 9 29.0 5 23.8 4 40.0 0.177
DGE 1 3.2 1 4.8 0 0 0.483
PPH 1 3.2 1 4.8 0 0 0.483
Grade of POPF
Grade A 11 35.5 7 33.3 4 40.0 0.237
Grade B 5 16.1 2 9.6 3 30.0 0.237
Grade C 0 0 0 0 0 0 d
^ p values for ODP vs. LDP.
POPF Z post operative pancreatic fistula; DGE Z delayed gastric emptying; PPH Z post pancreatectomy hemorrhage.
34 Y.F. Soh et al.comparatively, this balanced out the difficulties during the
operation resulting in comparable operative time. The
significantly greater EBL and amount of blood transfusion in
the ODP group supported this explanation. The feasibility of
LDP for the surgical treatment of pancreatic malignancies
depends significantly on its ability to offer robust lympha-
denectomies in comparison to ODP,36 which was not the
case in this study. A similar pattern was also observed inFigure 1 Distribution of postoperative pancreatic fistula
(POPF) according to ISGPS definition. There was no Grade C
POPF in either group.other studies where the number of nodes resected in
laparoscopic procedures was less than half of that in open
procedures.37 While this may be reflective of an inherent
drawback of LDP surgeries, the impact of such a finding on
the appraisal of LDP surgeries for the treatment of
pancreatic malignancies is so pivotal that we recommend
that more studies on this subject be carried out before we
come to definite conclusions.8,38e40
The third observation in our study was that the rates of
postoperative morbidities were comparable between the
LDP and ODP groups, suggesting similar safety profiles of
the two surgical modalities. In addition, we also found that
the new ISGPS definition inflated the postoperative
morbidity by approximately 30% in both groups when clin-
ically insignificant Grade A POPF was included in the ana-
lysis.This is consistent with the experience of other centers
that adopted this new definition.5 As expected, we
observed a significantly shorter postoperative LOS by 2 days
in the LDP group compared to the ODP group. That was the
advantage that was intended for minimally invasive
procedure. A recent collective review of studies on lapa-
roscopic distal pancreatectomy found that the mean LOS
across major centers in the USA was 5.3  1.1 days, while
mean LOS outside the USA was 7.4  5.0 days.8 In our
center, the median LOS for LDP was 5 (4e15) days. This
highlights the competitiveness of our institution’s health
care system and the effectiveness of a standardized post-
operative care and discharge pathway.
There are a few important limitations in our study. One
of the major aspects is the small sample size. Other
retrospective studies on LDP reported sample sizes of up to
90 patients.2,5,7 Other than that, there was a selection bias
in this study as there was a tendency to offer LDP for
patients with benign or premalignant conditions. These
lesions tend to be smaller in size compared to those in the
ODP. Elimination of this selection bias would require
a prospective randomized controlled study. This is
Table 7 Postoperative clinical outcomes.
All (n Z 31) ODP (n Z 21) LDP (n Z 10) p ^
Median length of stay in HD: d (range) 1 (0e5) 2 (0e5) 0 (0e1) 0.001*
Median length of stay in ICU: d (range) 0 (0e6) 0 (0e6) 0 (0e2) 0.400
Median post-operative length of stay: d (range) 7 (3e29) 7 (5e29) 5 (3e8) 0.020*
Median total length of stay: d (range) 7 (4e32) 8 (5e32) 5 (4e15) 0.016*
^ p values for ODP vs. LDP. * Statistically significant.
Laparoscopic and open distal pancreatectomy 35especially important if LDP were to be implemented as
standard of treatment for malignancies requiring distal
pancreatic resection.
5. Conclusion
The findings in our study validated the safety and efficacy
of LDP for the management of benign and premalignant
pancreatic lesions.41,42 Further studies on the oncologic
quality for LDP should be performed before applying this to
the management of pancreatic malignancies.43,44
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